A decade in prostate cancer: from NMR to metabolomics (Q37876681)

24 August 2017

1 reference

title

A decade in prostate cancer: from NMR to metabolomics (English)

1 reference

24 August 2017

1 reference

1 reference

Elita M DeFeo

1

1 reference

24 August 2017

Chin-Lee Wu

series ordinal

2

1 reference

24 August 2017

W Scott McDougal

series ordinal

3

1 reference

24 August 2017

Leo L Cheng

series ordinal

4

1 reference

24 August 2017

language of work or name

English

0 references

publication date

17 May 2011

1 reference

24 August 2017

Nature Reviews Urology

1 reference

24 August 2017

8

1 reference

24 August 2017

6

1 reference

24 August 2017

301-311

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2011.53

24 August 2017

0 references

cites work

Tumor Detection by Nuclear Magnetic Resonance

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Image Formation by Induced Local Interactions: Examples Employing Nuclear Magnetic Resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Computerized transverse axial scanning (tomography). 2. Clinical application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Computerized transverse axial scanning (tomography). 1. Description of system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Pathologic characterization of human prostate tissue with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologic study of diagnostic validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Proton HR‐MAS spectroscopy and quantitative pathologic analysis of MRI/3D‐MRSI‐targeted postsurgical prostate tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

High-resolution magic angle spinning proton NMR analysis of human prostate tissue with slow spinning rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Reduction of spinning sidebands in proton NMR of human prostate tissue with slow high-resolution magic angle spinning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Proton high-resolution magic angle spinning NMR analysis of fresh and previously frozen tissue of human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Improved signal to noise in high-resolution magic angle spinning total correlation spectroscopy studies of prostate tissues using rotor-synchronized adiabatic pulses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Semi-parametric time-domain quantification of HR-MAS data from prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Quantitative pathology in tissue MR spectroscopy based human prostate metabolomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Improved solvent suppression and increased spatial excitation bandwidths for three-dimensional PRESS CSI using phase-compensating spectral/spatial spin-echo pulses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

MR imaging-guided prostate biopsy with surgical navigation software: device validation and feasibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

A new robotic needle insertion method to minimise attendant prostate motion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Design of a novel MRI compatible manipulator for image guided prostate interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostate cancer: local staging at 3-T endorectal MR imaging--early experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostate cancer metabolite quantification relative to water in 1H-MRSI in vivo at 3 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

High-field MRSI of the prostate using a transmit/receive endorectal coil and gradient modulated adiabatic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Proton spectroscopic imaging of the human prostate at 7 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Use of perfluorocarbon compound in the endorectal coil to improve MR spectroscopy of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

3T MR of the prostate: reducing susceptibility gradients by inflating the endorectal coil with a barium sulfate suspension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Combined MRI and MRS in prostate cancer: improvement of spectral quality by susceptibility matching

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Automated estimation of tumor probability in prostate magnetic resonance spectroscopic imaging: pattern recognition vs quantification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Is it time to consider a role for MRI before prostate biopsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Lovastatin enhances phenylbutyrate-induced MR-visible glycerophosphocholine but not apoptosis in DU145 prostate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Modulation of choline kinase activity in human cancer cells observed by dynamic 31P NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Methods for metabolic evaluation of prostate cancer cells using proton and (13)C HR-MAS spectroscopy and [3-(13)C] pyruvate as a metabolic substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Bicarbonate increases tumor pH and inhibits spontaneous metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Hypoxia and the presence of human vascular endothelial cells affect prostate cancer cell invasion and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Investigation of tumor hyperpolarized [1-13C]-pyruvate dynamics using time-resolved multiband RF excitation echo-planar MRSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Optimizing PRESS localized citrate detection at 3 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Echo-time independent signal modulations using PRESS sequences: a new approach to spectral editing of strongly coupled AB spin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostate spectroscopy at 3 Tesla using two-dimensional S-PRESS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

High-speed 3T MR spectroscopic imaging of prostate with flyback echo-planar encoding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Two-dimensional MR spectroscopy of healthy and cancerous prostates in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Reduced power magnetic resonance spectroscopic imaging of the prostate at 4.0 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

In vivo lactate signal enhancement using binomial spectral-selective pulses in selective MQ coherence (SS-SelMQC) spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Assessing prostate cancer growth with mRNA of spermine metabolic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Registration methodology for histological sections and in vivo imaging of human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Technical note: fiducial markers for correlation of whole-specimen histopathology with MR imaging at 7 tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Semi-automatic deformable registration of prostate MR images to pathological slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Supervised and unsupervised methods for prostate cancer segmentation with multispectral MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Peripheral zone prostate cancer in patients with elevated PSA levels and low free-to-total PSA ratio: detection with MR imaging and MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Potential of (1)H MR spectroscopic imaging to segregate patients who are likely to show malignancy of the peripheral zone of the prostate on biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Cholesterol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Narrow band deformable registration of prostate magnetic resonance imaging, magnetic resonance spectroscopic imaging, and computed tomography studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Biological imaging in radiation oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

In vivo 13C NMR spectroscopy of the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Detection of polyunsaturated omega-6 fatty acid in human malignant prostate tissue by 1D and 2D high-resolution magic angle spinning NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

A new method to provide a fresh frozen prostate slice suitable for gene expression study and MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Numerical Methods in Function-Space

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Nuclear Magnetic Resonance Spectra from a Crystal rotated at High Speed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Identification of an endogenous inhibitor of prostatic carcinoma cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Combined MRI and MR spectroscopy of the prostate before radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostate cancer: 1.5 T endo-coil dynamic contrast-enhanced MRI and MR spectroscopy--correlation with prostate biopsy and prostatectomy histopathological data.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Magnetic resonance imaging of the prostate with spectroscopic imaging using a surface coil. Initial clinical experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Role of Dynamic Contrast-Enhanced Magnetic Resonance (MR) Imaging and Proton MR Spectroscopic Imaging in the Detection of Local Recurrence after Radical Prostatectomy for Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Transceive surface coil array for MRI of the human prostate at 4T

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Quantitative determination of sarcosine and related compounds in urinary samples by liquid chromatography with tandem mass spectrometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostate cancer detection with multi-parametric MRI: Logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Nuclear Magnetic Resonance Imaging of the Prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5 T

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

In vitro high resolution 1H-spectroscopy of the human prostate: benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

Proton MRS of human prostatic fluid: Correlations between citrate, spermine, andmyo-inositol levels and changes with disease

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRUROL.2011.53

31 March 2020

12 December 2020

Words of wisdom. Re: Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles. Maxeiner A, Adkins CB, Zhang Y, et al. Prostate 2010;70:710-7.

1 reference

12 December 2020

The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra.

1 reference

12 December 2020

Nuclear magnetic resonance investigations of human neoplastic and abnormal nonneoplastic tissues

1 reference

12 December 2020

Robotic image-guided needle interventions of the prostate

1 reference

12 December 2020

Metabolic response of the CWR22 prostate tumor xenograft after 20 Gy of radiation studied by 1H spectroscopic imaging.

1 reference

12 December 2020

Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy

1 reference

12 December 2020

Identifying prostate carcinoma by MALDI-Imaging.

1 reference

12 December 2020

Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy

1 reference

12 December 2020

Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells

1 reference

12 December 2020

Evaluation of Tissue Metabolites with High Resolution Magic Angle Spinning MR Spectroscopy Human Prostate Samples After Three-Year Storage at -80 degrees C.

1 reference

12 December 2020

Characterization of Prostate Cancer, Benign Prostatic Hyperplasia and Normal Prostates Using Transrectal31Phosphorus Magnetic Resonance Spectroscopy: A Preliminary Report

1 reference

12 December 2020

Registering histological and MR images of prostate for image-based cancer detection

1 reference

12 December 2020

Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles

1 reference

12 December 2020

Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer

1 reference

12 December 2020

Computerized transverse axial tomography.

1 reference

12 December 2020

Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.

1 reference

12 December 2020

Metabolomic imaging for human prostate cancer detection

1 reference

12 December 2020

Image registration for prostate MR spectroscopy using modeling and optimization of force and stiffness parameters.

1 reference

12 December 2020

The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2011.53

1 reference

24 August 2017

1 reference